Clinical Trial Update: Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating durvalumab and lenvatinib with or without chemotherapy as first-line treatment for advanced biliary tract cancer is ongoing (status u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Biliary Tract Neoplasms, Immunotherapy | Phase 2 | Status: UNKNOWN